GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GTBP is expected to report earnings to rise 3.73% to -250 cents per share on November 13
Q3'26
Est.
$-2.50
Q4'25
Missed
by $1.94
Q3'25
Missed
by $0.32
Q2'25
Est.
$-0.55
Q1'25
Beat
by $0.26
The last earnings report on March 02 showed earnings per share of -241 cents, missing the estimate of -46 cents. With 14.12K shares outstanding, the current market capitalization sits at 9.15M.